Clinic
Town Center Urgent Care LLC
Town Center Urgent Care LLC was paid $4.68M by Medicaid between Feb 2018 and Dec 2024, across 27 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 55% of everything it billed.
33Billing provider infoTOWN CENTER URGENT CARE LLC
GRUNDY, VA 24614
GRUNDY, VA 24614
33aNPI1386163822assigned 09/15/2017
33bProvider typeRural Health Clinic/Center
28Total paid$4.68M
24GClaims131,169
24DCodes billed27
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Virginia
Rank by total paid#1 of 66
Median peer was paid$195K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 653 | $24K | |
| 2019 | 5,288 | $143K | |
| 2020 | 6,789 | $245K | |
| 2021 | 20,353 | $739K | |
| 2022 | 31,849 | $1.17M | |
| 2023 | 37,206 | $1.27M | |
| 2024incomplete | 29,031 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 55% | 44,839 | 39,045 | $2.56M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 13% | 20,118 | 18,268 | $624K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 7,831 | 7,552 | $533K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.3% | 15,793 | 9,923 | $247K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.5% | 13,616 | 12,841 | $162K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.6% | 3,505 | 3,241 | $121K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.9% | 1,181 | 1,111 | $91K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.8% | 1,877 | 1,866 | $86K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 1,929 | 1,847 | $77K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 5,671 | 5,338 | $71K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 227 | 220 | $24K |
| 99201 | <1% | 714 | 698 | $22K |
15 more codes
| 87807 | <1% | 1,950 | $21K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 285 | $18K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 436 | $7K |
| 81002 | <1% | 2,583 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,995 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,883 | $5K |
| 0012A | <1% | 41 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 49 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 80 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 454 | $729.41 |
| 0011A | <1% | 41 | $528.70 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 29 | $154.66 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $104.57 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 13 | $7.92 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $0.57 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAYLOR, JEFFERY (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Medcura Health, INC. | Stone Mountain, GA | $1.40M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.